Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial

Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-14T02:01:31.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of a study evaluating the safety and efficacy of Surufatinib plus Sintilimab in patients with advanced solid tumors.
    Difference
    0.2%
    Check dated 2024-06-06T16:01:19.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns updates to the eligibility criteria for researchers looking for individuals with advanced or metastatic cancer for a clinical study involving Surufatinib plus Sintilimab.
    Difference
    22%
    Check dated 2024-05-22T07:31:52.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:17:59.000Z thumbnail image

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.